Dr. Healy received his undergraduate degree in Medicinal Chemistry from Trinity College Dublin, Ireland followed by an MSc in Biomedical Science from the University of Edinburgh, UK. He obtained his PhD in Chemistry in 2014 from the University of St. Andrews, UK, where he carried out research in Professor Nick Westwood's group. Subsequently, he carried out postdoctoral research at Yale University in the laboratory's of Professor Seth Herzon and Professor Jason Crawford where he studied the link between small molecule toxins produced by select strains of bacteria in the human gut and the development of colorectal cancer.

Dr. Healy's research at NYUAD is focused on using genomics, bioinformatics and automated chemical synthesis to discover, study and repurpose natural products as novel therapeutics.